VSIR Gene

Name V-set immunoregulatory receptor
Description Enables endopeptidase activator activity; enzyme binding activity; and identical protein binding activity. Involved in several processes, including negative regulation of cytokine production; positive regulation of metabolic process; and regulation of T cell activation. Located in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nVISTA (also known as VSIR) is a novel inhibitory immune checkpoint molecule that plays a critical role in maintaining immune homeostasis. It is constitutively expressed on naïve T cells and is highly enriched in cells of the myeloid lineage—including monocytes, macrophages, dendritic cells, and granulocytes—where it restrains T‐cell activation and thereby promotes peripheral tolerance. Unique structural features in its extracellular immunoglobulin–like domain (such as additional disulfide bonds and specialized loop regions) underpin its ability to engage binding partners (e.g. PSGL‐1 at acidic pH and VSIG‐3) to transmit inhibitory signals."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn numerous tumor microenvironments—including pancreatic, melanoma, lung, colorectal, ovarian and other cancers—VISTA is frequently upregulated, predominantly on tumor‐infiltrating immune cells such as macrophages and myeloid‐derived suppressor cells. This upregulation contributes to an immunosuppressive milieu that can impair anti–tumor T-cell responses and, in some settings, mediate resistance to existing checkpoint blockers (e.g. anti–PD-1/PD-L1 therapies). Moreover, studies in patient samples have correlated VISTA expression with distinct clinicopathologic features and survival outcomes—findings that vary with tumor type, reflecting its complex role as both a biomarker and a mediator of immune escape."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "26"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nTherapeutically, targeting the VISTA pathway—either alone or in combination with other checkpoint inhibitors—offers a promising strategy to overcome immune resistance in cancer. Preclinical investigations have shown that blockade of VISTA can reverse myeloid‐mediated T-cell suppression, enhance cytotoxic lymphocyte responses, and synergize with other therapies (including agents disrupting STAT3–driven transcriptional regulation) to improve tumor control. Beyond oncology, modulation of VISTA signaling is emerging as a potential approach to recalibrate immune responses in chronic infections, autoimmunity, and even in sepsis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "27", "end_ref": "40"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Moustafa A Sakr, Takahisa Takino, Takahiro Domoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GI24 enhances tumor invasiveness by regulating cell surface membrane-type 1 matrix metalloproteinase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1349-7006.2010.01675.x"}], "href": "https://doi.org/10.1111/j.1349-7006.2010.01675.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20666777"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20666777"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Preeti Bharaj, Harendra Singh Chahar, Ogechika K Alozie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of programmed death-1 homologue-1 (PD-1H) expression and function in normal and HIV infected individuals."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0109103"}], "href": "https://doi.org/10.1371/journal.pone.0109103"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25279955"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25279955"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Kyoung Wan Yoon, Sanguine Byun, Eunjeong Kwon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1261669"}], "href": "https://doi.org/10.1126/science.1261669"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26228159"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26228159"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Hojabr Kakavand, Louise A Jackett, Alexander M Menzies, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mod Pathol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/modpathol.2017.89"}], "href": "https://doi.org/10.1038/modpathol.2017.89"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28776578"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28776578"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Franz Villarroel-Espindola, Xiaoqing Yu, Ila Datar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-17-2542"}], "href": "https://doi.org/10.1158/1078-0432.CCR-17-2542"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29203588"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29203588"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Sabrina Ceeraz, Susan K Eszterhas, Petra A Sergent, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arthritis Res Ther (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13075-017-1474-y"}], "href": "https://doi.org/10.1186/s13075-017-1474-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29216931"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29216931"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Ming Zhang, Hua-Jin Pang, Wei Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-018-4435-1"}], "href": "https://doi.org/10.1186/s12885-018-4435-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29720116"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29720116"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Lawrence F Kuklinski, Shaofeng Yan, Zhongze Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Immunol Immunother (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00262-018-2169-1"}], "href": "https://doi.org/10.1007/s00262-018-2169-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29737375"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29737375"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Jinʼe Liu, Xiaoxue Xie, Chunxiao Xuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High-Density Infiltration of V-domain Immunoglobulin Suppressor of T-cell Activation Up-regulated Immune Cells in Human Pancreatic Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pancreas (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/MPA.0000000000001059"}], "href": "https://doi.org/10.1097/MPA.0000000000001059"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29771768"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29771768"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Zhaohui Dong, Lanying Zhang, Wei Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EGFR may participate in immune evasion through regulation of B7‑H5 expression in non‑small cell lung carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2018.9361"}], "href": "https://doi.org/10.3892/mmr.2018.9361"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30106102"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30106102"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Shan Xie, Jia Huang, Qin Qiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Immunol Immunother (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00262-018-2227-8"}], "href": "https://doi.org/10.1007/s00262-018-2227-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30128738"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30128738"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Jinghua Wang, Guoping Wu, Brian Manick, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VSIG-3 as a ligand of VISTA inhibits human T-cell function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunology (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/imm.13001"}], "href": "https://doi.org/10.1111/imm.13001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30220083"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30220083"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Kumuluzi Mulati, Junzo Hamanishi, Noriomi Matsumura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VISTA expressed in tumour cells regulates T cell function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41416-018-0313-5"}], "href": "https://doi.org/10.1038/s41416-018-0313-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30382166"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30382166"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Jorge Blando, Anu Sharma, Maria Gisela Higa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1811067116"}], "href": "https://doi.org/10.1073/pnas.1811067116"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30635425"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30635425"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Jie Deng, Jiannan Li, Aurelien Sarde, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Immunol Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/2326-6066.CIR-18-0507"}], "href": "https://doi.org/10.1158/2326-6066.CIR-18-0507"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31088847"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31088847"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Nishant Mehta, Sainiteesh Maddineni, Irimpan I Mathews, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure and Functional Binding Epitope of V-domain Ig Suppressor of T Cell Activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2019.07.073"}], "href": "https://doi.org/10.1016/j.celrep.2019.07.073"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31484064"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31484064"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Robert J Johnston, Linhui Julie Su, Jason Pinckney, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VISTA is an acidic pH-selective ligand for PSGL-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41586-019-1674-5"}], "href": "https://doi.org/10.1038/s41586-019-1674-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31645726"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31645726"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Sheera R Rosenbaum, Meghan Knecht, Mehri Mollaee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FOXD3 Regulates VISTA Expression in Melanoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2019.12.036"}], "href": "https://doi.org/10.1016/j.celrep.2019.12.036"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31940493"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31940493"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Mohamed A ElTanbouly, Yanding Zhao, Elizabeth Nowak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.aay0524"}], "href": "https://doi.org/10.1126/science.aay0524"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31949051"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31949051"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Xin-Lin He, Ying Zhou, Huan-Zi Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic value of VISTA in solid tumours: a systematic review and meta-analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-020-59608-w"}], "href": "https://doi.org/10.1038/s41598-020-59608-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32060343"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32060343"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Shumei Kato, Ryosuke Okamura, Yuichi Kumaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncoimmunology (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/2162402X.2019.1708065"}], "href": "https://doi.org/10.1080/2162402X.2019.1708065"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32117584"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32117584"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Shima Shahbaz, Garett Dunsmore, Petya Koleva, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Galectin-9 and VISTA Expression Define Terminally Exhausted T Cells in HIV-1 Infection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.1901481"}], "href": "https://doi.org/10.4049/jimmunol.1901481"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32205423"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32205423"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Liju Zong, Shengwei Mo, Shuangni Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of the immune checkpoint VISTA in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Immunol Immunother (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00262-020-02554-3"}], "href": "https://doi.org/10.1007/s00262-020-02554-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32266446"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32266446"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Xing Huang, Xiaozhen Zhang, Enliang Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hematol Oncol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13045-020-00917-y"}], "href": "https://doi.org/10.1186/s13045-020-00917-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32600443"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32600443"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Jae Won Choi, Young Jae Kim, Kyung A Yun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The prognostic significance of VISTA and CD33-positive myeloid cells in cutaneous melanoma and their relationship with PD-1 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-020-71216-2"}], "href": "https://doi.org/10.1038/s41598-020-71216-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32873829"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32873829"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Liju Zong, Shuangni Yu, Shengwei Mo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High VISTA Expression Correlates With a Favorable Prognosis in Patients With Colorectal Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunother (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/CJI.0000000000000343"}], "href": "https://doi.org/10.1097/CJI.0000000000000343"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33086339"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33086339"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Mohamed A ElTanbouly, Evelien Schaafsma, Nicole C Smits, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VISTA Re-programs Macrophage Biology Through the Combined Regulation of Tolerance and Anti-inflammatory Pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Immunol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fimmu.2020.580187"}], "href": "https://doi.org/10.3389/fimmu.2020.580187"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33178206"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33178206"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Xiaoxue Xie, Junying Zhang, Zhongyuan Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Immunol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fimmu.2020.563044"}], "href": "https://doi.org/10.3389/fimmu.2020.563044"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33250890"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33250890"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Inna M Yasinska, N Helge Meyer, Stephanie Schlichtner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ligand-Receptor Interactions of Galectin-9 and VISTA Suppress Human T Lymphocyte Cytotoxic Activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Immunol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fimmu.2020.580557"}], "href": "https://doi.org/10.3389/fimmu.2020.580557"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33329552"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33329552"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Nora Wuerdemann, Katharina Pütz, Hans Eckel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAG-3, TIM-3 and VISTA Expression on Tumor-Infiltrating Lymphocytes in Oropharyngeal Squamous Cell Carcinoma-Potential Biomarkers for Targeted Therapy Concepts."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms22010379"}], "href": "https://doi.org/10.3390/ijms22010379"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33396515"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33396515"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Won Ik Seo, Chan Ho Lee, Soo Jin Jung, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of VISTA on tumor-infiltrating immune cells correlated with short intravesical recurrence in non-muscle-invasive bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Immunol Immunother (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00262-021-02906-7"}], "href": "https://doi.org/10.1007/s00262-021-02906-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33770210"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33770210"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Hai-Xia He, Yan Gao, Jian-Chang Fu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncoimmunology (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/2162402X.2021.1907059"}], "href": "https://doi.org/10.1080/2162402X.2021.1907059"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33889438"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33889438"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Bryan M Rogers, Laura Smith, Zoltan Dezso, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VISTA is an activating receptor in human monocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20201601"}], "href": "https://doi.org/10.1084/jem.20201601"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34106206"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34106206"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Amina Ghouzlani, Abdelhakim Lakhdar, Soumaya Rafii, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-021-00835-0"}], "href": "https://doi.org/10.1038/s41598-021-00835-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34728682"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34728682"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Long Long, Li Zhang, Yuhan Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Different clinical significance of novel B7 family checkpoints VISTA and HHLA2 in human lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunotherapy (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/imt-2021-0093"}], "href": "https://doi.org/10.2217/imt-2021-0093"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35187955"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35187955"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Łukasz Zapała, Michał Kunc, Sumit Sharma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Immune checkpoint receptor VISTA on immune cells is associated with expression of T-cell exhaustion marker TOX and worse prognosis in renal cell carcinoma with venous tumor thrombus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cancer Res Clin Oncol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00432-022-04329-y"}], "href": "https://doi.org/10.1007/s00432-022-04329-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36042047"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36042047"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Jianshan Mo, Lin Deng, Keren Peng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hematol Oncol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13045-023-01410-y"}], "href": "https://doi.org/10.1186/s13045-023-01410-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36849939"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36849939"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Negar Hosseinkhani, Nima Hemmat, Elham Baghbani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dual silencing of tumor-intrinsic VISTA and CTLA-4 stimulates T-cell mediated immune responses and inhibits MCF7 breast cancer development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2023.148043"}], "href": "https://doi.org/10.1016/j.gene.2023.148043"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38042220"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38042220"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Fereshteh Rezagholizadeh, Fatemeh Tajik, Morteza Talebi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Immunol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fimmu.2024.1283364"}], "href": "https://doi.org/10.3389/fimmu.2024.1283364"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38357542"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38357542"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Hieu Minh Ta, Dia Roy, Keman Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LRIG1 engages ligand VISTA and impairs tumor-specific CD8[+] T cell responses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Immunol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/sciimmunol.adi7418"}], "href": "https://doi.org/10.1126/sciimmunol.adi7418"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38758807"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38758807"}]}]}]}
NCBI Gene ID 64115
API
Download Associations
Predicted Functions View VSIR's ARCHS4 Predicted Functions.
Co-expressed Genes View VSIR's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View VSIR's ARCHS4 Predicted Functions.

Functional Associations

VSIR has 2,060 functional associations with biological entities spanning 6 categories (functional term, phrase or reference, chemical, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 29 datasets.

Click the + buttons to view associations for VSIR from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Proteomics Cell lines associated with VSIR protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with VSIR gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of VSIR gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing VSIR protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with VSIR protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of VSIR protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by VSIR gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with VSIR gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with VSIR gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with VSIR gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with VSIR gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
GO Biological Process Annotations 2023 biological processes involving VSIR gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving VSIR gene from the curated GO Biological Process Annotations2025 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by VSIR gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by VSIR gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of VSIR gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of VSIR gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of VSIR gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
IMPC Knockout Mouse Phenotypes phenotypes of mice caused by VSIR gene knockout from the IMPC Knockout Mouse Phenotypes dataset.
Kinase Library Tyrosine Kinome Atlas kinases that phosphorylate VSIR protein from the Kinase Library Tyrosine Kinome Atlas dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by VSIR gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of VSIR gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of VSIR gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of VSIR gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of VSIR gene from the RummaGEO Gene Perturbation Signatures dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of VSIR protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of VSIR protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with VSIR protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2024 pathways involving VSIR protein from the WikiPathways Pathways 2024 dataset.